Thorazine: Effective Antipsychotic Relief for Severe Mental Disorders
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.67 | $40.42 (0%) | 🛒 Add to cart |
| 90 | $0.62 | $60.63 $55.90 (8%) | 🛒 Add to cart |
| 120 | $0.56 | $80.84 $67.08 (17%) | 🛒 Add to cart |
| 180 | $0.49 | $121.26 $88.58 (27%) | 🛒 Add to cart |
| 270 | $0.43 | $181.89 $116.10 (36%) | 🛒 Add to cart |
| 360 | $0.38
Best per pill | $242.52 $138.46 (43%) | 🛒 Add to cart |
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.49 | $43.86 (0%) | 🛒 Add to cart |
| 120 | $0.44 | $58.48 $53.32 (9%) | 🛒 Add to cart |
| 180 | $0.42 | $87.72 $74.82 (15%) | 🛒 Add to cart |
| 270 | $0.39 | $131.58 $106.64 (19%) | 🛒 Add to cart |
| 360 | $0.38
Best per pill | $175.44 $138.46 (21%) | 🛒 Add to cart |
Synonyms | |||
Thorazine (chlorpromazine hydrochloride) is a first-generation antipsychotic medication indicated for the management of manifestations of psychotic disorders, including schizophrenia. It functions primarily as a dopamine antagonist, aiding in the reduction of hallucinations, delusions, and aggressive behavior. Clinically, it is also utilized in the treatment of acute intermittent porphyria, severe behavioral problems in children, and as an antiemetic. Its efficacy has been established through decades of use in both inpatient and outpatient psychiatric settings, providing clinicians with a reliable option for patients with treatment-resistant or acute psychotic symptoms.
Features
- Active ingredient: chlorpromazine hydrochloride
- Available in multiple formulations: tablets, syrup, and injectable solutions
- Demonstrated efficacy in controlling positive symptoms of psychosis
- Also possesses antiemetic, antihistaminic, and sedative properties
- Suitable for both acute management and maintenance therapy
Benefits
- Reduces frequency and intensity of hallucinations and delusions
- Helps restore functional behavior and improves patient cooperation
- Can decrease agitation and aggression in acute settings
- Provides long-term stability for chronic psychotic conditions
- May alleviate severe nausea and vomiting in certain clinical scenarios
- Offers a cost-effective option within its therapeutic class
Common use
Thorazine is primarily prescribed for the treatment of schizophrenia and other psychotic disorders where symptoms such as disorganized thinking, emotional withdrawal, and hostility are present. It is also used off-label for the management of bipolar disorder during manic episodes, severe anxiety, and intractable hiccups. In pediatric populations, it may be administered under strict supervision for severe behavioral disturbances or hyperactive states. Its antiemetic properties make it useful in controlling nausea and vomiting associated with chemotherapy or surgery.
Dosage and direction
Dosage must be individualized based on severity of condition, patient response, and tolerability. For adult psychosis, initial oral doses typically range from 30–75 mg daily, divided into 2–4 administrations, gradually increasing to 200–800 mg daily based on clinical response. Injectable forms are reserved for acute agitation, with doses of 25–50 mg administered intramuscularly. Maintenance doses are generally lower. Elderly or debilitated patients should receive lower initial doses. Always take with food or milk to minimize gastrointestinal upset unless otherwise directed.
Precautions
Use with caution in patients with cardiovascular disease, glaucoma, or seizure disorders. May impair mental or physical abilities required for hazardous tasks; advise against driving or operating machinery until response is known. Periodic liver function tests, complete blood counts, and ophthalmologic exams are recommended during prolonged therapy. Avoid abrupt discontinuation to prevent withdrawal symptoms or rebound psychosis. Not recommended during pregnancy unless potential benefit justifies potential risk.
Contraindications
Contraindicated in patients with known hypersensitivity to chlorpromazine or phenothiazines. Do not use in comatose states, significant central nervous system depression, or bone marrow suppression. Avoid in patients with suspected subcortical brain damage due to risk of severe adverse reactions. Concomitant use with large doses of hypnotics is contraindicated.
Possible side effect
Common side effects include drowsiness, dizziness, dry mouth, blurred vision, and constipation. Extrapyramidal symptoms such as Parkinsonism, dystonia, and akathisia may occur. Tardive dyskinesia—sometimes irreversible—has been reported with long-term use. Other potential adverse reactions include orthostatic hypotension, photosensitivity, weight gain, and neuroleptic malignant syndrome. Endocrine disturbances such as galactorrhea and menstrual irregularities may also present.
Drug interaction
Thorazine may potentiate effects of CNS depressants including alcohol, barbiturates, and opioids. Concurrent use with antihypertensive agents may increase risk of hypotension. Anticholinergic drugs may enhance certain side effects. May reduce effects of oral anticoagulants and levodopa. Use with caution alongside QT-prolonging agents due to potential additive effects on cardiac repolarization.
Missed dose
If a dose is missed, take it as soon as remembered unless it is almost time for the next dose. Do not double the dose to catch up. Maintain regular scheduling to ensure consistent therapeutic levels. Consult a healthcare provider if multiple doses are missed, as abrupt changes may affect symptom control.
Overdose
Symptoms of overdose include severe drowsiness, hypotension, tachycardia, agitation, convulsions, and coma. Management is supportive and may include gastric lavage, administration of activated charcoal, and maintaining airway and cardiovascular function. There is no specific antidote. Extrapyramidal symptoms may be treated with antiparkinsonian agents. Contact poison control or emergency services immediately.
Storage
Store at room temperature (15–30°C) in a tightly closed container, protected from light and moisture. Do not freeze liquid formulations. Keep out of reach of children and pets. Dispose of unused medication via take-back programs or according to local regulations.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, changing, or discontinuing any medication. Individual responses may vary.
Reviews
Clinical studies and long-term observational data support the efficacy of Thorazine in managing acute and chronic psychosis. Many clinicians value its predictable pharmacokinetics and well-understood side effect profile. Some patients report significant improvement in quality of life and symptom reduction, though side effects—particularly sedation and extrapyramidal symptoms—are frequently noted. It remains a foundational agent in psychiatric pharmacotherapy.